February 2015 Newsletter

February 19, 2015:

Private Equity Firm Acquires LASIK Vision Institute and TLC Laser Eye Centers

Sources say the brands will be kept separate, but some consolidation is occurring at the corporate level.

February 19, 2015:

LCA-Vision Sold Back to Company Founder

Stephen Joffe, MD, has regained control of LASIKPlus laser centers.

February 19, 2015:

Actavis to Take Allergan’s Name Following Completion of Merger

The Actavis moniker will be maintained for select regions and product portfolios.

February 19, 2015:

Spark’s $161M IPO Stresses Promise of Gene Therapy

Shares doubled in price the first day of trading, jumping from $23 to $50.

February 19, 2015:

Presbia Raises $42 Million in Initial Public Offering

The Irvine, CA-based company markets the Presbia Flexivue Microlens corneal inlay for the treatment of presbyopia.

February 19, 2015:

Ocata Therapeutics Withdraws Stock Offering

The company cited market conditions as the reason for the pullback.

February 19, 2015:

Two FDA Advisory Panels to Jointly Review Avedro’s Crosslinking Technology

The meeting is set for February 24 at the FDA White Oak campus.

February 19, 2015:

Two TECNIS Multifocal Lenses Gain FDA Approval

The new models are designed to provide customized vision based on the lifestyle needs of each cataract patient.

February 19, 2015:

Lucentis Receives New Approval in Treatment of Diabetic Retinopathy

This makes it the first drug in the treatment armamentarium for the progressive vision-threatening condition that is so common among people suffering from diabetes.

February 19, 2015:

Report: Drug Prices Rose Nearly 11 Percent in 2014

Branded prescription pharmaceuticals experienced the steepest climb with a 14.8 percent increase.

February 19, 2015:

Global Increases in Procedures to Fuel Growth in Ophthalmic Surgical Instruments Market

Revenues are expected to total nearly $1.3 billion in 2020.

February 19, 2015:

STAAR Warns Investors of Possible Delay in Approval of Visian TICL

Concerns raised by FDA during recent inspections may lead to more regulatory actions.

February 19, 2015:

Presbyopia Surgery Market Proves Challenging but Promising Long Term

Revenues are forecast to grow to more than $750 million by 2019.

February 19, 2015:

Current ICD-10 Deadline Gets Widespread Support at Hearing

Seven witnesses testified at the hearing of the House Energy and Commerce Committee’s Subcommittee on Health.

February 19, 2015:

February 2015 News Briefs

Social media